EX-23.2 3 d208981dex232.htm EX-23.2 EX-23.2

Exhibit 23.2

 

LOGO      
  

KPMG LLP

Two Financial Center

60 South Street

Boston, MA 02111

  

Consent of Independent Registered Public Accounting Firm

We consent to the use of our report dated March 3, 2025, with respect to the consolidated financial statements of Viridian Therapeutics, Inc., and the effectiveness of internal control over financial reporting, incorporated herein by reference.

/s/ KPMG LLP

Boston, Massachusetts

March 3, 2025

KPMG LLP, a Delaware limited liability partnership and a member firm of

the KPMG global organization of independent member firms affiliated with

KPMG International Limited, a private English company limited by guarantee.